Prospective Study of Cerebrovascular Accidents (CVA) in 3 French Cities (Besançon, Cayenne and Tours)
NCT ID: NCT04925869
Last Updated: 2021-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2019-05-07
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Social and Prognostic Inequalities in Patients Hospitalised for Cerebrovascular Accident (CVA) in Four Contrasting French Departments
NCT01906463
Neurothrombectomy France
NCT02880579
Unruptured Cerebral Aneurysm: Prediction of Evolution
NCT04578808
Observational Study of Patients With Subarachnoid Hemorrhage
NCT02890004
Carotid Web and Stroke Registry.
NCT05475080
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Epidemiological studies show disparities in stroke mortality and vascular risk factors between French regions. The stroke mortality rate in French Guiana in 2013 (72 per 100 000 population per year) was twice that of metropolitan France. The standardized prevalence rate of diabetes in French Guiana is 7.1% of the population compared with 4.4% in metropolitan France, and the prevalence of hypertension is twice as high among women in the French Guiana West Indies compared with metropolitan France. There are twice as many obese persons (BMI\>30) in Guyanese women compared with metropolitan France.
We propose a prospective observational study based on the following hypothesis:
The average age of stroke occurrence, its type (ischemic or hemorrhagic), the vascular territories involved, the vascular risk factors, and the pre-hospital and intra-hospital management times will be superimposable between two metropolitan regions but different in French Guyana.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The hospitals of Besançon
Adult patients with MRI-confirmed CVA admitted to the hospitals of Besançon
Observational study
Observational study
the hospitals of Cayenne
Adult patients with MRI-confirmed CVA admitted to the hospitals of Cayenne.
Observational study
Observational study
the hospitals of Tours
Adult patients with MRI-confirmed CVA admitted to the hospitals of Tours.
Observational study
Observational study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational study
Observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Absence of MRI
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Régional Universitaire de Tours
OTHER_GOV
Centre Hospitalier Régional Universitaire, Besançon
UNKNOWN
Centre Hospitalier de Cayenne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bertrand De Toffol, PHD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier de Cayenne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier de Cayenne
Cayenne, Guiana, French Guiana
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AVC BCT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.